Skip to main content
Top
Published in: Endocrine 1/2017

01-10-2017 | Review

Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review

Authors: Matthias Büttner, Thomas J. Musholt, Susanne Singer

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Purpose

Hypoparathyroidism is a rare endocrine disorder for which replacement therapy of the missing parathyroid hormone is not the standard therapeutic option. Current standard treatment consists of calcium and vitamin D supplementation. The intake of calcium and vitamin D supplementation can lead to complications and therefore might negatively influence patients’ quality of life.

Methods

A systematic literature review was performed to assess the current knowledge on the influence of hypoparathyroidism on patients’ quality of life. The literature search was conducted in PubMed and Web of Science; all relevant literature published by August 24, 2016, was included.

Results

In total 372 records were found. After title and abstract screening, 14 studies remained for a full-text screening. The full-text screening resulted in five studies which were included into the systematic review. Comparing the results with a norm-based reference population, three studies reported lower SF-36 scores for hypoparathyroidism patients. Two studies showed a reduced quality of life in hypoparathyroidism patients when their results were compared to control populations.

Conclusion

Most hypoparathyroidism patients receiving standard treatment show stable calcium and vitamin D levels. However, hypoparathyroidism patients still report reduced quality of life and experience physical, mental, and emotional symptoms. Therefore, it is assumed that the lack of parathyroid hormone directly influences the patients’ quality of life. This review indicates that patients with hypoparathyroidism have a reduced quality of life in comparison to norm-based populations or matched controls. Further studies are required to quantify the effect of hypoparathyroidism on patients’ quality of life using disease-specific questionnaires and controlling for the co-morbidities and etiologies of the patients.
Literature
1.
2.
go back to reference A. Bergenfelz, S. Jansson, A. Kristoffersson, H. Martensson, E. Reihner, G. Wallin et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3660 patients. Langenbecks Arch. Surg. 393(5), 667–673 (2008)CrossRefPubMed A. Bergenfelz, S. Jansson, A. Kristoffersson, H. Martensson, E. Reihner, G. Wallin et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3660 patients. Langenbecks Arch. Surg. 393(5), 667–673 (2008)CrossRefPubMed
3.
go back to reference O. Thomusch, A. Machens, C. Sekulla, J. Ukkat, M. Brauckhoff, H. Dralle, The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 133(2), 180–185 (2003)CrossRefPubMed O. Thomusch, A. Machens, C. Sekulla, J. Ukkat, M. Brauckhoff, H. Dralle, The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 133(2), 180–185 (2003)CrossRefPubMed
4.
go back to reference L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 28(11), 2277–2285 (2013)CrossRefPubMed L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J. Bone Miner. Res. 28(11), 2277–2285 (2013)CrossRefPubMed
5.
go back to reference L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J. Bone Miner. Res. 30(9), 1738–1744 (2015)CrossRefPubMed L. Underbjerg, T. Sikjaer, L. Mosekilde, L. Rejnmark, The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J. Bone Miner. Res. 30(9), 1738–1744 (2015)CrossRefPubMed
6.
go back to reference J. Powers, K. Joy, A. Ruscio, H. Lagast, Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J. Bone Miner. Res. 28(12), 2570–2576 (2013)CrossRefPubMed J. Powers, K. Joy, A. Ruscio, H. Lagast, Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J. Bone Miner. Res. 28(12), 2570–2576 (2013)CrossRefPubMed
7.
go back to reference M.C. Astor, K. Lovas, A. Debowska, E.F. Eriksen, J.A. Evang, C. Fossum et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J. Clin. Endocrinol. Metab. 101(8), 3045–3053 (2016)CrossRefPubMedPubMedCentral M.C. Astor, K. Lovas, A. Debowska, E.F. Eriksen, J.A. Evang, C. Fossum et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J. Clin. Endocrinol. Metab. 101(8), 3045–3053 (2016)CrossRefPubMedPubMedCentral
8.
go back to reference W. Arlt, C. Fremerey, F. Callies, M. Reincke, P. Schneider, W. Timmermann et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur. J. Endocrinol. 146(2), 215–222 (2002)CrossRefPubMed W. Arlt, C. Fremerey, F. Callies, M. Reincke, P. Schneider, W. Timmermann et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur. J. Endocrinol. 146(2), 215–222 (2002)CrossRefPubMed
9.
go back to reference G. Marcucci, G. Della Pepa, M.L. Brandi, Natpara for the treatment of hypoparathyroidism. Expert. Opin. Biol. Ther. 16(11), 1417–1424 (2016)CrossRefPubMed G. Marcucci, G. Della Pepa, M.L. Brandi, Natpara for the treatment of hypoparathyroidism. Expert. Opin. Biol. Ther. 16(11), 1417–1424 (2016)CrossRefPubMed
10.
go back to reference J.P. Bilezikian, A. Khan, J.T. Potts Jr., M.L. Brandi, B.L. Clarke, D. Shoback et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 26(10), 2317–2337 (2011)CrossRefPubMedPubMedCentral J.P. Bilezikian, A. Khan, J.T. Potts Jr., M.L. Brandi, B.L. Clarke, D. Shoback et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 26(10), 2317–2337 (2011)CrossRefPubMedPubMedCentral
11.
go back to reference R. Herzog, M.J. Alvarez-Pasquin, C. Diaz, J.L. Del Barrio, J.M. Estrada, A. Gil, Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13, 154 (2013)CrossRefPubMedPubMedCentral R. Herzog, M.J. Alvarez-Pasquin, C. Diaz, J.L. Del Barrio, J.M. Estrada, A. Gil, Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13, 154 (2013)CrossRefPubMedPubMedCentral
12.
go back to reference N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, A. Tulley, J. Sliney Jr et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J. Clin. Endocrinol. Metab. 98(6), 2356–2361 (2013)CrossRefPubMedPubMedCentral N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, A. Tulley, J. Sliney Jr et al. The effect of PTH(1-84) on quality of life in hypoparathyroidism. J. Clin. Endocrinol. Metab. 98(6), 2356–2361 (2013)CrossRefPubMedPubMedCentral
13.
go back to reference T. Sikjaer, L. Rolighed, A. Hess, A. Fuglsang-Frederiksen, L. Mosekilde, L. Rejnmark, Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos. Int. 25(6), 1717–1726 (2014)CrossRefPubMed T. Sikjaer, L. Rolighed, A. Hess, A. Fuglsang-Frederiksen, L. Mosekilde, L. Rejnmark, Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos. Int. 25(6), 1717–1726 (2014)CrossRefPubMed
14.
go back to reference T. Sikjaer, E. Moser, L. Rolighed, L. Underbjerg, L.S. Bislev, L. Mosekilde et al. Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J. Bone Miner. Res. 31(7), 1440–1448 (2016)CrossRefPubMed T. Sikjaer, E. Moser, L. Rolighed, L. Underbjerg, L.S. Bislev, L. Mosekilde et al. Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J. Bone Miner. Res. 31(7), 1440–1448 (2016)CrossRefPubMed
15.
go back to reference J.E. Ware Jr., C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30(6), 473–483 (1992)CrossRefPubMed J.E. Ware Jr., C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30(6), 473–483 (1992)CrossRefPubMed
16.
go back to reference J.H. Loge, S. Kaasa, Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand. J. Soc. Med. 26(4), 250–258 (1998)CrossRefPubMed J.H. Loge, S. Kaasa, Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand. J. Soc. Med. 26(4), 250–258 (1998)CrossRefPubMed
17.
go back to reference K. Lovas, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison’s disease. Clin. Endocrinol. 56(5), 581–588 (2002)CrossRef K. Lovas, J.H. Loge, E.S. Husebye, Subjective health status in Norwegian patients with Addison’s disease. Clin. Endocrinol. 56(5), 581–588 (2002)CrossRef
18.
go back to reference I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453–459 (2010)CrossRefPubMed I. Nermoen, E.S. Husebye, J. Svartberg, K. Lovas, Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453–459 (2010)CrossRefPubMed
19.
go back to reference N. Hadker, J. Egan, J. Sanders, H. Lagast, B.L. Clarke, Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr. Pract. 20(7), 671–679 (2014)CrossRefPubMed N. Hadker, J. Egan, J. Sanders, H. Lagast, B.L. Clarke, Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study. Endocr. Pract. 20(7), 671–679 (2014)CrossRefPubMed
20.
go back to reference A.G. Bago, E. Dimitrov, R. Saunders, L. Seress, M. Palkovits, T.B. Usdin et al. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162(1), 128–147 (2009)CrossRefPubMedPubMedCentral A.G. Bago, E. Dimitrov, R. Saunders, L. Seress, M. Palkovits, T.B. Usdin et al. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162(1), 128–147 (2009)CrossRefPubMedPubMedCentral
21.
go back to reference S. Balabanov, U. Tollner, H.P. Richter, F. Pohlandt, G. Gaedicke, W.M. Teller, Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol. 106(2), 227–233 (1984)PubMed S. Balabanov, U. Tollner, H.P. Richter, F. Pohlandt, G. Gaedicke, W.M. Teller, Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol. 106(2), 227–233 (1984)PubMed
22.
go back to reference P. Divieti, N. Inomata, K. Chapin, R. Singh, H. Juppner, F.R. Bringhurst, Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology 142(2), 916–925 (2001)CrossRefPubMed P. Divieti, N. Inomata, K. Chapin, R. Singh, H. Juppner, F.R. Bringhurst, Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology 142(2), 916–925 (2001)CrossRefPubMed
23.
go back to reference T.B. Usdin, T.I. Bonner, S.R. Hoare, The parathyroid hormone 2 (PTH2) receptor. Recept. Channels 8(3-4), 211–218 (2002)CrossRefPubMed T.B. Usdin, T.I. Bonner, S.R. Hoare, The parathyroid hormone 2 (PTH2) receptor. Recept. Channels 8(3-4), 211–218 (2002)CrossRefPubMed
24.
go back to reference N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, L. Anderson, E. Levy et al. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J. Clin. Endocrinol. Metab. 99(10), 3694–3699 (2014)CrossRefPubMedPubMedCentral N.E. Cusano, M.R. Rubin, D.J. McMahon, D. Irani, L. Anderson, E. Levy et al. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J. Clin. Endocrinol. Metab. 99(10), 3694–3699 (2014)CrossRefPubMedPubMedCentral
25.
go back to reference A. Santonati, A. Palermo, E. Maddaloni, D. Bosco, A. Spada, F. Grimaldi et al. PTH(1-34) for surgical hypoparathyroidism: A prospective, open-label investigation of efficacy and quality of life. J. Clin. Endocrinol. Metab. 100(9), 3590–3597 (2015)CrossRefPubMed A. Santonati, A. Palermo, E. Maddaloni, D. Bosco, A. Spada, F. Grimaldi et al. PTH(1-34) for surgical hypoparathyroidism: A prospective, open-label investigation of efficacy and quality of life. J. Clin. Endocrinol. Metab. 100(9), 3590–3597 (2015)CrossRefPubMed
26.
go back to reference N.L. Cho, J. Moalem, L. Chen, C.C. Lubitz, F.D. Moore Jr., D.T. Ruan, Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr. Pract. 20(5), 427–446 (2014)CrossRefPubMed N.L. Cho, J. Moalem, L. Chen, C.C. Lubitz, F.D. Moore Jr., D.T. Ruan, Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr. Pract. 20(5), 427–446 (2014)CrossRefPubMed
27.
go back to reference W. Arlt, F. Callies, J.C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341(14), 1013–1020 (1999)CrossRefPubMed W. Arlt, F. Callies, J.C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341(14), 1013–1020 (1999)CrossRefPubMed
28.
go back to reference P. Saravanan, W.F. Chau, N. Roberts, K. Vedhara, R. Greenwood, C.M. Dayan, Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin. Endocrinol. 57(5), 577–585 (2002)CrossRef P. Saravanan, W.F. Chau, N. Roberts, K. Vedhara, R. Greenwood, C.M. Dayan, Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin. Endocrinol. 57(5), 577–585 (2002)CrossRef
29.
go back to reference O. Husson, H.R. Haak, W.A. Oranje, F. Mols, P.H. Reemst, L.V. van de Poll-Franse, Health-related quality of life among thyroid cancer survivors: a systematic review. Clin. Endocrinol. 75(4), 544–554 (2011)CrossRef O. Husson, H.R. Haak, W.A. Oranje, F. Mols, P.H. Reemst, L.V. van de Poll-Franse, Health-related quality of life among thyroid cancer survivors: a systematic review. Clin. Endocrinol. 75(4), 544–554 (2011)CrossRef
30.
go back to reference H.C. Hoftijzer, K.A. Heemstra, E.P. Corssmit, A.A. van der Klaauw, J.A. Romijn, J.W. Smit, Quality of life in cured patients with differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 93(1), 200–203 (2008)CrossRefPubMed H.C. Hoftijzer, K.A. Heemstra, E.P. Corssmit, A.A. van der Klaauw, J.A. Romijn, J.W. Smit, Quality of life in cured patients with differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 93(1), 200–203 (2008)CrossRefPubMed
31.
go back to reference S. Singer, T. Lincke, E. Gamper, K. Bhaskaran, S. Schreiber, A. Hinz et al. Quality of life in patients with thyroid cancer compared with the general population. Thyroid 22(2), 117–124 (2012)CrossRefPubMed S. Singer, T. Lincke, E. Gamper, K. Bhaskaran, S. Schreiber, A. Hinz et al. Quality of life in patients with thyroid cancer compared with the general population. Thyroid 22(2), 117–124 (2012)CrossRefPubMed
Metadata
Title
Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review
Authors
Matthias Büttner
Thomas J. Musholt
Susanne Singer
Publication date
01-10-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1377-3

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.